CorMedix CRMD
NASDAQ CRMD
$5.30 -0.07 (-1.30%)
At close: Nov 11, 2026 · 4:00 PM EST

CorMedix (CRMD) Gains (Losses) on Sale of Assets & Investments (2015 - 2026)

Updated

CorMedix's Non Operating Investment Income was $2.55 million in Q2 2026.

Analysis

CorMedix (CRMD) Gains (Losses) on Sale of Assets & Investments (2015 - 2026) Analysis & Trends

On a trailing twelve-month basis, CorMedix's Non Operating Investment Income was $7.91 million through Jun 30, 2026; for FY2025, it came in at $5.36 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 CorMedix 417.07 Mn -222.82 Mn 77.13 Mn 2.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.55 Mn
Mar 31, 2026 -3.55 Mn
Dec 31, 2025 2.27 Mn
Sep 30, 2025 3.09 Mn
Dec 31, 2024 2,031.00
Sep 30, 2024 5,040.00
Mar 31, 2024 -10,903.00
Dec 31, 2023 8,593.00
Sep 30, 2023 -4,571.00
Jun 30, 2023 -10,732.00
Mar 31, 2023 16,393.00
Dec 31, 2022 24,732.00
Sep 30, 2022 15,811.00
Jun 30, 2022 -1,316.00
Mar 31, 2022 -34,171.00
Dec 31, 2021 -4,642.00
Sep 30, 2021 302.00
Jun 30, 2021 -662.00
Mar 31, 2021 347.00
Dec 31, 2020 -1,078.00
API Access

CorMedix Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CRMD&period=max&api_key=YOUR_API_KEY